A method of treating iron induced cardiac disease in a patient with iron overload, such as in thalassemia or the like comprising administering to the patient a therapeutically effective amount of deferiprone or a physiologically acceptable salt thereof sufficient to treat iron induced cardiac disease normally associated with iron overload.

 
Web www.patentalert.com

< Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use

< C-nitroso compounds and use thereof

> Tissue discrimination and applications in medical procedures

> Stent overlap point markers

~ 00264